Pain Control for Intrauterine Device Placement: A Randomized Controlled Trial of Paracervical Block
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pain Due to Intrauterine Contraceptive Device
- Sponsor
- University of California, San Diego
- Enrollment
- 67
- Locations
- 2
- Primary Endpoint
- Pain With Intrauterine Device (IUD) Placement
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Intrauterine device (IUD) placement can be painful for patients during and after the procedure. Fear of pain from IUD insertion can be a barrier to obtaining this highly effective long acting reversible contraception. Currently there are no proven effective methods for reduction of pain during and after placement of modern IUDs. Paracervical block pain may decrease this placement pain.
Detailed Description
Modern IUDs are highly effective long acting reversible forms of contraception. The Mirena IUD is 99.8% effective and the Paragard copper IUD is 99.2% effective in preventing pregnancy. Fear of IUD placement can be a barrier to obtaining this highly effective form of birth control. The current standard of care for pain management during and after IUD placement is no medication, as randomized control trials published to date have limited data regarding use of medications to decrease pain. There has been one trial to suggest that the use of naproxen with 1% lidocaine paracervical block (PCB) compared to PCB alone may decrease pain after IUD placement in primarily nulliparous patients. However, this study was with the much wider and no longer available Dalkon Shield IUD. In addition, this study did not show any significant decrease in pain scores during IUD placement. Studies to evaluate effectiveness of ibuprofen and misoprostol have shown no significant decrease in pain scores during and after IUD insertion, although the majority of participants in these studies were multiparous. There is some suggestion that 2% lidocaine gel one minute prior to IUD insertion may have some decrease in pain, although this study was poorly designed. Although there is no standard of care in regards to pain medication administration prior to IUD placement, providers often suggest paracervical prior IUD insertion among nulliparous women. Therefore the primary aim of this study is to determine whether a paracervical block (PCB) decreases pain associated with intrauterine device (IUD) placement compared to no paracervical block. We hypothesize that administration of a PCB of 20 mL 1% buffered lidocaine prior to IUD placement will decrease pain scores by at least 20mm on a visual analog scale at various time points during IUD placement when compared to no paracervical block.
Investigators
Sheila Mody
Women's Reproductive Health Research (K12) Scholar
University of California, San Diego
Eligibility Criteria
Inclusion Criteria
- •Nulliparous women
- •English or Spanish speaking
- •Present for intrauterine device placement for contraception or menorrhagia (in the case of Mirena IUD insertion).
Exclusion Criteria
- •Pregnancy
- •Any diagnosed chronic pain issues (i.e. fibromyalgia, endometriosis, dysmenorrhea, irritable bowel syndrome, interstitial cystitis)
- •If the patient has taken any pain medications within 6 hours of enrollment, including aspirin or other NSAIDs
- •Misoprostol administration within 24 hours of enrollment
- •History of prior IUD insertion
- •Known contraindications to IUD
Outcomes
Primary Outcomes
Pain With Intrauterine Device (IUD) Placement
Time Frame: Moment of IUD insertion
Distance (mm) from the left of the 100-mm visual analog scale (reflecting magnitude of pain) recorded at time of IUD Placement. Scale range is from 0mm (no pain) to 100mm (worst pain possible). A lower score (less pain) is considered a better outcome.
Secondary Outcomes
- Median Pain Scores for All Time Points(Anticipation of procedure through 5 minutes after IUD placement)